United States Immunotoxins Market Report 2018

March 2018 | 96 pages | ID: UDF3D7B5CE6QEN
QYResearch

Abstracts

In this report, the United States Immunotoxins market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Immunotoxins in these regions, from 2013 to 2025 (forecast).

United States Immunotoxins market competition by top manufacturers/players, with Immunotoxins sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Biotest
• Celldex Therapeutics
• Amgen
• Genmab
• AREVA Med
• Bayer HealthCare
• Neurocrine Biosciences
• Research Corporation Technologies
• CuraGen Corporation
• Genentech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Anthrax Based Toxins
• Diphtheria Toxin (DT) & DT Derivatives
• Pseudomonas Exotoxin (PE) & PE Derivatives
• Ribosome Inactivating Proteins Based Immunotoxins
• Ribonucleases based Immunotoxins
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Solid Tumors
• Leukemias

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Immunotoxins Market Report 2018

1 IMMUNOTOXINS OVERVIEW

1.1 Product Overview and Scope of Immunotoxins
1.2 Classification of Immunotoxins by Product Category
  1.2.1 United States Immunotoxins Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Immunotoxins Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Anthrax Based Toxins
  1.2.4 Diphtheria Toxin (DT) & DT Derivatives
  1.2.5 Pseudomonas Exotoxin (PE) & PE Derivatives
  1.2.6 Ribosome Inactivating Proteins Based Immunotoxins
  1.2.7 Ribonucleases based Immunotoxins
  1.2.8 Others
1.3 United States Immunotoxins Market by Application/End Users
  1.3.1 United States Immunotoxins Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Solid Tumors
  1.3.3 Leukemias
1.4 United States Immunotoxins Market by Region
  1.4.1 United States Immunotoxins Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Immunotoxins Status and Prospect (2013-2025)
  1.4.3 Southwest Immunotoxins Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Immunotoxins Status and Prospect (2013-2025)
  1.4.5 New England Immunotoxins Status and Prospect (2013-2025)
  1.4.6 The South Immunotoxins Status and Prospect (2013-2025)
  1.4.7 The Midwest Immunotoxins Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Immunotoxins (2013-2025)
  1.5.1 United States Immunotoxins Sales and Growth Rate (2013-2025)
  1.5.2 United States Immunotoxins Revenue and Growth Rate (2013-2025)

2 UNITED STATES IMMUNOTOXINS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Immunotoxins Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Immunotoxins Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Immunotoxins Average Price by Players/Suppliers (2013-2018)
2.4 United States Immunotoxins Market Competitive Situation and Trends
  2.4.1 United States Immunotoxins Market Concentration Rate
  2.4.2 United States Immunotoxins Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Immunotoxins Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IMMUNOTOXINS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Immunotoxins Sales and Market Share by Region (2013-2018)
3.2 United States Immunotoxins Revenue and Market Share by Region (2013-2018)
3.3 United States Immunotoxins Price by Region (2013-2018)

4 UNITED STATES IMMUNOTOXINS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Immunotoxins Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Immunotoxins Revenue and Market Share by Type (2013-2018)
4.3 United States Immunotoxins Price by Type (2013-2018)
4.4 United States Immunotoxins Sales Growth Rate by Type (2013-2018)

5 UNITED STATES IMMUNOTOXINS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Immunotoxins Sales and Market Share by Application (2013-2018)
5.2 United States Immunotoxins Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMMUNOTOXINS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Biotest
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Immunotoxins Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Biotest Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Celldex Therapeutics
  6.2.2 Immunotoxins Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Celldex Therapeutics Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Amgen
  6.3.2 Immunotoxins Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Amgen Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Genmab
  6.4.2 Immunotoxins Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Genmab Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 AREVA Med
  6.5.2 Immunotoxins Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AREVA Med Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Bayer HealthCare
  6.6.2 Immunotoxins Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer HealthCare Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Neurocrine Biosciences
  6.7.2 Immunotoxins Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Neurocrine Biosciences Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Research Corporation Technologies
  6.8.2 Immunotoxins Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Research Corporation Technologies Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 CuraGen Corporation
  6.9.2 Immunotoxins Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 CuraGen Corporation Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Genentech
  6.10.2 Immunotoxins Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Genentech Immunotoxins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 IMMUNOTOXINS MANUFACTURING COST ANALYSIS

7.1 Immunotoxins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immunotoxins

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Immunotoxins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immunotoxins Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMMUNOTOXINS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Immunotoxins Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Immunotoxins Sales Volume Forecast by Type (2018-2025)
11.3 United States Immunotoxins Sales Volume Forecast by Application (2018-2025)
11.4 United States Immunotoxins Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Immunotoxins
Figure United States Immunotoxins Market Size (K Pcs) by Type (2013-2025)
Figure United States Immunotoxins Sales Volume Market Share by Type (Product Category) in 2017
Figure Anthrax Based Toxins Product Picture
Figure Diphtheria Toxin (DT) & DT Derivatives Product Picture
Figure Pseudomonas Exotoxin (PE) & PE Derivatives Product Picture
Figure Ribosome Inactivating Proteins Based Immunotoxins Product Picture
Figure Ribonucleases based Immunotoxins Product Picture
Figure Others Product Picture
Figure United States Immunotoxins Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Immunotoxins by Application in 2017
Figure Solid Tumors Examples
Table Key Downstream Customer in Solid Tumors
Figure Leukemias Examples
Table Key Downstream Customer in Leukemias
Figure United States Immunotoxins Market Size (Million USD) by Region (2013-2025)
Figure The West Immunotoxins Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Immunotoxins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Immunotoxins Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Immunotoxins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Immunotoxins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Immunotoxins Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immunotoxins Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Immunotoxins Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immunotoxins Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Immunotoxins Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Immunotoxins Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immunotoxins Sales Share by Players/Suppliers
Figure 2017 United States Immunotoxins Sales Share by Players/Suppliers
Figure United States Immunotoxins Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Immunotoxins Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Immunotoxins Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immunotoxins Revenue Share by Players/Suppliers
Figure 2017 United States Immunotoxins Revenue Share by Players/Suppliers
Table United States Market Immunotoxins Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Immunotoxins Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Immunotoxins Market Share of Top 3 Players/Suppliers
Figure United States Immunotoxins Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immunotoxins Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immunotoxins Product Category
Table United States Immunotoxins Sales (K Pcs) by Region (2013-2018)
Table United States Immunotoxins Sales Share by Region (2013-2018)
Figure United States Immunotoxins Sales Share by Region (2013-2018)
Figure United States Immunotoxins Sales Market Share by Region in 2017
Table United States Immunotoxins Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Immunotoxins Revenue Share by Region (2013-2018)
Figure United States Immunotoxins Revenue Market Share by Region (2013-2018)
Figure United States Immunotoxins Revenue Market Share by Region in 2017
Table United States Immunotoxins Price (USD/Pcs) by Region (2013-2018)
Table United States Immunotoxins Sales (K Pcs) by Type (2013-2018)
Table United States Immunotoxins Sales Share by Type (2013-2018)
Figure United States Immunotoxins Sales Share by Type (2013-2018)
Figure United States Immunotoxins Sales Market Share by Type in 2017
Table United States Immunotoxins Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Immunotoxins Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immunotoxins by Type (2013-2018)
Figure Revenue Market Share of Immunotoxins by Type in 2017
Table United States Immunotoxins Price (USD/Pcs) by Types (2013-2018)
Figure United States Immunotoxins Sales Growth Rate by Type (2013-2018)
Table United States Immunotoxins Sales (K Pcs) by Application (2013-2018)
Table United States Immunotoxins Sales Market Share by Application (2013-2018)
Figure United States Immunotoxins Sales Market Share by Application (2013-2018)
Figure United States Immunotoxins Sales Market Share by Application in 2017
Table United States Immunotoxins Sales Growth Rate by Application (2013-2018)
Figure United States Immunotoxins Sales Growth Rate by Application (2013-2018)
Table Biotest Basic Information List
Table Biotest Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biotest Immunotoxins Sales Growth Rate (2013-2018)
Figure Biotest Immunotoxins Sales Market Share in United States (2013-2018)
Figure Biotest Immunotoxins Revenue Market Share in United States (2013-2018)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celldex Therapeutics Immunotoxins Sales Growth Rate (2013-2018)
Figure Celldex Therapeutics Immunotoxins Sales Market Share in United States (2013-2018)
Figure Celldex Therapeutics Immunotoxins Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Amgen Immunotoxins Sales Growth Rate (2013-2018)
Figure Amgen Immunotoxins Sales Market Share in United States (2013-2018)
Figure Amgen Immunotoxins Revenue Market Share in United States (2013-2018)
Table Genmab Basic Information List
Table Genmab Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genmab Immunotoxins Sales Growth Rate (2013-2018)
Figure Genmab Immunotoxins Sales Market Share in United States (2013-2018)
Figure Genmab Immunotoxins Revenue Market Share in United States (2013-2018)
Table AREVA Med Basic Information List
Table AREVA Med Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AREVA Med Immunotoxins Sales Growth Rate (2013-2018)
Figure AREVA Med Immunotoxins Sales Market Share in United States (2013-2018)
Figure AREVA Med Immunotoxins Revenue Market Share in United States (2013-2018)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer HealthCare Immunotoxins Sales Growth Rate (2013-2018)
Figure Bayer HealthCare Immunotoxins Sales Market Share in United States (2013-2018)
Figure Bayer HealthCare Immunotoxins Revenue Market Share in United States (2013-2018)
Table Neurocrine Biosciences Basic Information List
Table Neurocrine Biosciences Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Neurocrine Biosciences Immunotoxins Sales Growth Rate (2013-2018)
Figure Neurocrine Biosciences Immunotoxins Sales Market Share in United States (2013-2018)
Figure Neurocrine Biosciences Immunotoxins Revenue Market Share in United States (2013-2018)
Table Research Corporation Technologies Basic Information List
Table Research Corporation Technologies Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Research Corporation Technologies Immunotoxins Sales Growth Rate (2013-2018)
Figure Research Corporation Technologies Immunotoxins Sales Market Share in United States (2013-2018)
Figure Research Corporation Technologies Immunotoxins Revenue Market Share in United States (2013-2018)
Table CuraGen Corporation Basic Information List
Table CuraGen Corporation Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure CuraGen Corporation Immunotoxins Sales Growth Rate (2013-2018)
Figure CuraGen Corporation Immunotoxins Sales Market Share in United States (2013-2018)
Figure CuraGen Corporation Immunotoxins Revenue Market Share in United States (2013-2018)
Table Genentech Basic Information List
Table Genentech Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech Immunotoxins Sales Growth Rate (2013-2018)
Figure Genentech Immunotoxins Sales Market Share in United States (2013-2018)
Figure Genentech Immunotoxins Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunotoxins
Figure Manufacturing Process Analysis of Immunotoxins
Figure Immunotoxins Industrial Chain Analysis
Table Raw Materials Sources of Immunotoxins Major Players/Suppliers in 2017
Table Major Buyers of Immunotoxins
Table Distributors/Traders List
Figure United States Immunotoxins Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Immunotoxins Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Immunotoxins Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Immunotoxins Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Immunotoxins Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Immunotoxins Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Immunotoxins Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immunotoxins Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immunotoxins Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources